相似文献
1
Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.
Surv Ophthalmol. 2014 Jan-Feb;59(1):64-76. doi: 10.1016/j.survophthal.2013.02.005. Epub 2013 Sep 5.
2
Sphingolipids in ocular inflammation.
Adv Exp Med Biol. 2014;801:623-9. doi: 10.1007/978-1-4614-3209-8_78.
3
Role of Bioactive Sphingolipids in Inflammation and Eye Diseases.
Adv Exp Med Biol. 2019;1161:149-167. doi: 10.1007/978-3-030-21735-8_14.
4
Molecular facets of sphingolipids: mediators of diseases.
Biotechnol J. 2009 Jul;4(7):1028-41. doi: 10.1002/biot.200800322.
5
Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Chem Phys Lipids. 2012 May;165(4):462-74. doi: 10.1016/j.chemphyslip.2012.02.006. Epub 2012 Feb 23.
6
Sphingolipids and neuronal degeneration in lysosomal storage disorders.
J Neurochem. 2019 Mar;148(5):600-611. doi: 10.1111/jnc.14540. Epub 2018 Aug 16.
7
Ophthalmologic aspects of lipid storage diseases.
Ophthalmology. 1978 Oct;85(10):1007-13. doi: 10.1016/s0161-6420(78)35592-5.
8
The sphiningolipidoses: an overview.
Postgrad Med. 1977 Mar;61(3):90-3, 95. doi: 10.1080/00325481.1977.11712151.
9
Sphingolipid profile alters in retinal dystrophic P23H-1 rats and systemic FTY720 can delay retinal degeneration.
J Lipid Res. 2016 May;57(5):818-31. doi: 10.1194/jlr.M063719. Epub 2016 Mar 5.
10
Neuronal sphingolipidoses: Membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism.
Biochimie. 2016 Nov;130:146-151. doi: 10.1016/j.biochi.2016.05.004. Epub 2016 May 5.
引用本文的文献
1
Tay-Sachs disease in a child of indigenous Guatemalan-Mayan origin with macular brown spots and perifoveal whitening.
Am J Ophthalmol Case Rep. 2025 Jul 8;39:102381. doi: 10.1016/j.ajoc.2025.102381. eCollection 2025 Sep.
2
Novel insights into pathomechanisms of retinal neuronal degeneration and reactive gliosis in a murine model of G-gangliosidosis.
Sci Rep. 2025 Aug 13;15(1):29674. doi: 10.1038/s41598-025-15639-9.
3
Plasma Sphingomyelins as Biomarkers for Diabetic Retinal Neurodegeneration: The Maastricht Study.
Ophthalmol Sci. 2025 Jun 27;5(6):100870. doi: 10.1016/j.xops.2025.100870. eCollection 2025 Nov-Dec.
4
Advances in Diagnosis, Pathological Mechanisms, Clinical Impact, and Future Therapeutic Perspectives in Tay-Sachs Disease.
Neurol Int. 2025 Jun 25;17(7):98. doi: 10.3390/neurolint17070098.
5
Mouse Model of Nitrogen Mustard Ocular Surface Injury Characterization and Sphingolipid Signaling.
Int J Mol Sci. 2024 Jan 6;25(2):742. doi: 10.3390/ijms25020742.
6
Central retinal artery occlusion without cherry-red spots.
BMC Ophthalmol. 2023 Oct 25;23(1):434. doi: 10.1186/s12886-023-03176-w.
7
Targeting GM2 Ganglioside Accumulation in Dementia: Current Therapeutic Approaches and Future Directions.
Curr Mol Med. 2024;24(11):1329-1345. doi: 10.2174/0115665240264547231017110613.
8
Metabolomic profiling of a neurodegenerative retina following optic nerve transection.
Mol Med Rep. 2023 Sep;28(3). doi: 10.3892/mmr.2023.13065. Epub 2023 Aug 4.
9
A Comprehensive Profiling of Cellular Sphingolipids in Mammalian Endothelial and Microglial Cells Cultured in Normal and High-Glucose Conditions.
Cells. 2022 Sep 30;11(19):3082. doi: 10.3390/cells11193082.
10
Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia.
Exp Eye Res. 2022 Nov;224:109250. doi: 10.1016/j.exer.2022.109250. Epub 2022 Sep 16.
本文引用的文献
1
Targeted knockdown of Cerkl, a retinal dystrophy gene, causes mild affectation of the retinal ganglion cell layer.
Biochim Biophys Acta. 2012 Aug;1822(8):1258-69. doi: 10.1016/j.bbadis.2012.04.004. Epub 2012 Apr 19.
2
Microcystic macular oedema in multiple sclerosis is associated with disease severity.
Brain. 2012 Jun;135(Pt 6):1786-93. doi: 10.1093/brain/aws098. Epub 2012 Apr 25.
3
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
J Neurosci. 2012 Apr 18;32(16):5585-97. doi: 10.1523/JNEUROSCI.5705-11.2012.
4
The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models.
Diabetes. 2011 Sep;60(9):2370-8. doi: 10.2337/db10-0550. Epub 2011 Jul 19.
5
Many ceramides.
J Biol Chem. 2011 Aug 12;286(32):27855-62. doi: 10.1074/jbc.R111.254359. Epub 2011 Jun 21.
6
Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice.
J Neurochem. 2011 Mar;116(5):779-88. doi: 10.1111/j.1471-4159.2010.07034.x. Epub 2011 Jan 7.
7
Spatiotemporal expression pattern of ceramide kinase-like in the mouse retina.
Mol Vis. 2010 Dec 3;16:2539-49.
8
Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa.
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18706-11. doi: 10.1073/pnas.1007644107. Epub 2010 Oct 11.
9
An overview of sphingolipid metabolism: from synthesis to breakdown.
Adv Exp Med Biol. 2010;688:1-23. doi: 10.1007/978-1-4419-6741-1_1.
10
An introduction to sphingolipid metabolism and analysis by new technologies.
Neuromolecular Med. 2010 Dec;12(4):306-19. doi: 10.1007/s12017-010-8132-8. Epub 2010 Aug 3.
Zotero 插件